News and Presentations

Meet VAR2 Pharmaceuticals at the World ADC Event Series in San Diego

VAR2 Pharmaceuticals receives approval for first-in-human PET/CT imaging study with Vartumabs

Meet VAR2 Pharmaceuticals and VARCT Diagnostics at ESMO 2024 in Barcelona

New publication in Nature Communications on the development of VAR2 Pharma’s first-in-class antibodies – Vartumabs – and their pre-clinical validation as a platform for cancer therapeutics

New publication in Cell Reports Medicine uses recombinant VAR2CSA to isolate circulating tumor cells and generate patient-relevant mouse models for pancreatic cancer

VAR2 PHARMA TO ATTEND THE 2024 BIO-EUROPE PARTNERING CONFERENCE

News

Meet VAR2 Pharmaceuticals at the World ADC Event Series in San Diego

VAR2 Pharmaceuticals receives approval for first-in-human PET/CT imaging study with Vartumabs

Meet VAR2 Pharmaceuticals and VARCT Diagnostics at ESMO 2024 in Barcelona

Meet our board and management

Meet our executive team

Meet our collaborators

© Var2 Pharmaceuticals ApS. All rights reserved. 2024

Privacy Policy
Build with by Simple Digital ApS

This website uses cookies.

Our website only uses strictly necessary cookies. Please consult our Privacy Policy for additional information on how we process your data.